Skip to content

Clinical trials

Withdrawn Sleep Initiation and Maintenance Disorders trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Initiation and Maintenance Disorders Phase: Not applicable Status: Withdrawn Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20121
20152
20161
20182
20191
20201
20212
20225
20234
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wake Forest University Health Sciences2
Abramson Cancer Center at Penn Medicine1
Afeka, The Tel-Aviv Academic College of Engineering1
Chinese University of Hong Kong1
Christina Murphey, RN, PhD1
Guy's and St Thomas' NHS Foundation Trust1
Istituti Clinici Scientifici Maugeri SpA1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McMaster University1
Milton S. Hershey Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Initiation and Maintenance Disorders26
Anxiety Disorders5
Breast Neoplasms2
Chronic Pain2
Attention Deficit Disorder with Hyperactivity1
Burnout, Professional1
Disorders of Excessive Somnolence1
Fatigue1
Gastroparesis1
Lung Neoplasms1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.